Do Wall Street Analysts Like Cencora Stock?

Conshohocken, Pennsylvania-based Cencora, Inc. (COR) is a pharmaceutical sourcing and distribution company. With a market cap of approximately $54 billion, Cencora operates through the U.S. Healthcare Solutions and International Healthcare Solutions segments, providing pharmaceutical supplies, healthcare products, and services to various healthcare providers.

The pharma distributor has significantly outperformed the broader market over the past year. COR stock has soared 25.2% over the past 52 weeks and 24.2% on a YTD basis, compared to the S&P 500 Index’s ($SPX) 12.7% gains over the past year and a marginal 8 bps uptick in 2025.